Cargando…
Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27(Kip1)
BACKGROUND: It was reported recently that resveratrol could sensitize a number of cancer cells to the antitumoral effects of some conventional chemotherapy drugs. The current study was designed to investigate whether resveratrol could sensitize leukemic cells to proteasome inhibitors. METHODS: Leuke...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066124/ https://www.ncbi.nlm.nih.gov/pubmed/21418583 http://dx.doi.org/10.1186/1471-2407-11-99 |
_version_ | 1782201047735861248 |
---|---|
author | Niu, Xiao-Fang Liu, Bao-Qin Du, Zhen-Xian Gao, Yan-Yan Li, Chao Li, Ning Guan, Yifu Wang, Hua-Qin |
author_facet | Niu, Xiao-Fang Liu, Bao-Qin Du, Zhen-Xian Gao, Yan-Yan Li, Chao Li, Ning Guan, Yifu Wang, Hua-Qin |
author_sort | Niu, Xiao-Fang |
collection | PubMed |
description | BACKGROUND: It was reported recently that resveratrol could sensitize a number of cancer cells to the antitumoral effects of some conventional chemotherapy drugs. The current study was designed to investigate whether resveratrol could sensitize leukemic cells to proteasome inhibitors. METHODS: Leukemic cells were treated with MG132 alone or in combination with resveratrol. Cell viability was investigated using MTT assay, and induction of apoptosis and cell cycle distribution was measured using flow cytometry. Western blot and real-time RT-PCR were used to investigate the expression of FOXO1 and p27(Kip1). CHIP was performed to investigate the binding of FOXO1 to the p27 (Kip1 )promoter. RESULTS: Resveratrol strongly reduced cytotoxic activities of proteasome inhibitors against leukemic cells. MG132 in combination with resveratrol caused cell cycle blockade at G1/S transition via p27(Kip1 )accumulation. Knockdown of p27(Kip1 )using siRNA dramatically attenuated the protective effects of resveratrol on cytotoxic actions of proteasome inhibitors against leukemic cells. Resveratrol induced FOXO1 expression at the transcriptional level, while MG132 increased nuclear distribution of FOXO1. MG132 in combination with resveratrol caused synergistic induction of p27(Kip1 )through increased recruitment of FOXO1 on the p27(Kip1 )promoter. CONCLUSIONS: Resveratrol may have the potential to negate the cytotoxic effects of proteasome inhibitors via regulation of FOXO1 transcriptional activity and accumulation of p27(Kip1). |
format | Text |
id | pubmed-3066124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30661242011-03-30 Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27(Kip1) Niu, Xiao-Fang Liu, Bao-Qin Du, Zhen-Xian Gao, Yan-Yan Li, Chao Li, Ning Guan, Yifu Wang, Hua-Qin BMC Cancer Research Article BACKGROUND: It was reported recently that resveratrol could sensitize a number of cancer cells to the antitumoral effects of some conventional chemotherapy drugs. The current study was designed to investigate whether resveratrol could sensitize leukemic cells to proteasome inhibitors. METHODS: Leukemic cells were treated with MG132 alone or in combination with resveratrol. Cell viability was investigated using MTT assay, and induction of apoptosis and cell cycle distribution was measured using flow cytometry. Western blot and real-time RT-PCR were used to investigate the expression of FOXO1 and p27(Kip1). CHIP was performed to investigate the binding of FOXO1 to the p27 (Kip1 )promoter. RESULTS: Resveratrol strongly reduced cytotoxic activities of proteasome inhibitors against leukemic cells. MG132 in combination with resveratrol caused cell cycle blockade at G1/S transition via p27(Kip1 )accumulation. Knockdown of p27(Kip1 )using siRNA dramatically attenuated the protective effects of resveratrol on cytotoxic actions of proteasome inhibitors against leukemic cells. Resveratrol induced FOXO1 expression at the transcriptional level, while MG132 increased nuclear distribution of FOXO1. MG132 in combination with resveratrol caused synergistic induction of p27(Kip1 )through increased recruitment of FOXO1 on the p27(Kip1 )promoter. CONCLUSIONS: Resveratrol may have the potential to negate the cytotoxic effects of proteasome inhibitors via regulation of FOXO1 transcriptional activity and accumulation of p27(Kip1). BioMed Central 2011-03-19 /pmc/articles/PMC3066124/ /pubmed/21418583 http://dx.doi.org/10.1186/1471-2407-11-99 Text en Copyright ©2011 Niu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Niu, Xiao-Fang Liu, Bao-Qin Du, Zhen-Xian Gao, Yan-Yan Li, Chao Li, Ning Guan, Yifu Wang, Hua-Qin Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27(Kip1) |
title | Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27(Kip1) |
title_full | Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27(Kip1) |
title_fullStr | Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27(Kip1) |
title_full_unstemmed | Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27(Kip1) |
title_short | Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27(Kip1) |
title_sort | resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of foxo1 and p27(kip1) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066124/ https://www.ncbi.nlm.nih.gov/pubmed/21418583 http://dx.doi.org/10.1186/1471-2407-11-99 |
work_keys_str_mv | AT niuxiaofang resveratrolprotectsleukemiccellsagainstcytotoxicityinducedbyproteasomeinhibitorsviainductionoffoxo1andp27kip1 AT liubaoqin resveratrolprotectsleukemiccellsagainstcytotoxicityinducedbyproteasomeinhibitorsviainductionoffoxo1andp27kip1 AT duzhenxian resveratrolprotectsleukemiccellsagainstcytotoxicityinducedbyproteasomeinhibitorsviainductionoffoxo1andp27kip1 AT gaoyanyan resveratrolprotectsleukemiccellsagainstcytotoxicityinducedbyproteasomeinhibitorsviainductionoffoxo1andp27kip1 AT lichao resveratrolprotectsleukemiccellsagainstcytotoxicityinducedbyproteasomeinhibitorsviainductionoffoxo1andp27kip1 AT lining resveratrolprotectsleukemiccellsagainstcytotoxicityinducedbyproteasomeinhibitorsviainductionoffoxo1andp27kip1 AT guanyifu resveratrolprotectsleukemiccellsagainstcytotoxicityinducedbyproteasomeinhibitorsviainductionoffoxo1andp27kip1 AT wanghuaqin resveratrolprotectsleukemiccellsagainstcytotoxicityinducedbyproteasomeinhibitorsviainductionoffoxo1andp27kip1 |